- Global Pharma News & Resources

Press Releases - 2021-12-22

Date Title Company
22-Dec-2021 Biophytis announces the drawing of the last tranche of ORNANE under the 2020 Atlas Contract for €3 million Biophytis
22-Dec-2021 Survey shows US health care providers lack trust in drug-related marketing content provided by pharmaceutical companies Three Whiskey
22-Dec-2021 ViiV Healthcare announces US FDA approval of Apretude (cabotegravir extended-release injectable suspension), the first and only long-acting injectable option for HIV prevention ViiV Healthcare
22-Dec-2021 National Institute for Health and Care Excellence Backs Darzalex®▼ (daratumumab) in Combination with Velcade® (bortezomib), Thalidomide and Dexamethasone (DVTd) for Patients with Newly Diagnosed Multiple Myeloma Janssen Pharmaceutical Companies of Johnson & Johnson
22-Dec-2021 EXACT Therapeutics AS Announces Allowance of Patent Application in Europe for Acoustic Cluster Therapy (ACT®) EXACT Therapeutics AS
22-Dec-2021 Arix Bioscience co-leads $31 million Series A financing for new portfolio company Sorriso Pharmaceuticals Arix Bioscience
22-Dec-2021 Qualer Has Added New Automation Software Features for Their Asset Maintenance Software Solutions Newswire
22-Dec-2021 IoM Hospice and digital health company leading clinical study to inform global dementia care Memory Lane Games
22-Dec-2021 Gyroscope Therapeutics to be acquired for up to $1.5 billion Gyroscope Therapeutics
22-Dec-2021 Medpoint secures finance to provide innovative tech for pharmacies Medpoint
22-Dec-2021 Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Receives FDA Fast Track Designation for Varoglutamstat in Early Alzheimer's Disease (news with additional features) Vivoryon Therapeutics N.V.